| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-04-28 | Validive® (clonidine Lauriad®) | chemoradiation therapy induced oral mucositis in patients with head and neck cancer | 2 | Onxeo - previously known as Bioalliance Pharma (France) | Cancer - Oncology |
| 2016-04-28 | ALKS 7119 | treatment of agitation in patients with Alzheimer’s disease, major depressive disorder (MDD) and other central nervous system (CNS) indications | 1 | Alkermes (Ireland) | Neurodegenerative diseases - CNS diseases |
| 2016-04-28 | Rayaldee™ ( calcifediol - vitamin D prohormone) | secondary hyperparathyroidism (SHPT) | Opko Health (USA - Fl) | Hormonal diseases - Endocrine diseases | |
| 2016-04-28 | SHP465 (triple-bead mixed amphetamine salts - MAS) | Attention-Deficit Hyperactivity Disorder (ADHD) | 3 | Shire (UK - USA) | CNS diseases - Mental diseases - Neurological diseases |
| 2016-04-28 | relacorilant (CORT125134) | solid tumors | preclinical | Corcept Therapeutics (USA - CA) | Cancer - Oncology |
| 2016-04-27 | AT132 | X-linked myotubular myopathy (XLMTM) | preclinical | Audentes Therapeutics (USA - CA) Genethon (France) | Rare diseases - Genetic diseases - Neuromuscular diseases |
| 2016-04-27 | AT132 | X-linked Myotubular Myopathy (XLMTM) | preclinical | Audentes Therapeutics (USA - CA) | Rare diseases - Genetic diseases - Neuromuscular diseases |
| 2016-04-27 | INO-8000 | hepatitis C | 1 | Inovio Pharmaceuticals (USA - PA) | Infectious diseases |
| 2016-04-27 | sublingual house dust mite and Japanese cedar pollen immunotherapy tablets (STAGR120) | seasonal allergic rhinitis induced by Japanese Cedar pollen | 2 | Shionogi (Japan) Stallergenes Greer (UK) | Allergic diseases - Immunological diseases - Respiratory diseases |
| 2016-04-27 | Jetrea® (ocriplasmin) | Thrombogenics (Belgium) | Ophtalmological diseases | ||
| 2016-04-27 | Paclical®/Apealea® (paclitaxel) | epithelial ovarian cancer | 3 | Oasmia Pharmaceutical (Sweden) | Cancer - Oncology |
| 2016-04-27 | glembatumumab vedotin (CDX-011) | squamous cell carcinoma of the lung | 1-2 | Celldex Therapeutics (USA - NJ) PrECOG (USA - PA) | Cancer - Oncology |
| 2016-04-27 | BioChaperone Lispro® | type 2 diabetes | 1b | Adocia (France) Eli Lilly (USA - IN) | Metabolic diseases |
| 2016-04-26 | recAP - recombinant alkaline phosphatase | sepsis-associated Acute Kidney Injury (AKI) | 2 | Am-Pharma (The Netherlands) | Infectious diseases - Kidney diseases |
| 2016-04-26 | AZP-531 (unacylated ghrelin analog) | Prader-Willi syndrome | 2 | Alize Pharma (France) | Rare diseases - Genetic diseases |
| 2016-04-26 | brilacidin | acute bacterial skin and skin structure infections (ABSSSI) | 3 | Cellceutix (USA - MA) now Innovation Pharmaceuticals (USA - MA) | Infectious diseases |
| 2016-04-25 | TSR-022 | 1 | Tesaro (US - MA) | Cancer - Oncology | |
| 2016-04-25 | GLP-1 (glucagon-like peptide 1) and glucagon receptors | Heptares Therapeutics (UK), a wholly-owned subsidiary of Sosei Group (Japan) | Metabolic diseases | ||
| 2016-04-25 | SelectMDx™ for Prostate Cancer | prostate cancer | MDxHealth (Belgium) | Cancer - Oncology | |
| 2016-04-22 | rAAV2-CB-hRPE65 | Leber congenital amaurosis (LCA), severe early-childhood-onset retinal degeneration (SECORD) | 1-2 | AGTC (USA - FL) | Rare diseases - Genetic diseases - Ophtalmological diseases |
